APOE and Alzheimer disease: In mouse models of AD, the switch from a microglial homeostatic phenotype to a disease-associated phenotype involves upregulation of a set of genes, including the AD-associated gene APOE, and downregulation of the core microglial transcriptomic signature (Keren-Shaul et al., 2017; Krasemann et al., 2017).